In a large multicentre, retrospective, cohort study involving 232 cancer patients and 519 patients without cancer, increased TNF-α and IL-6, as well as decreased lymphocytes and CD4+ T cells, were found to be risk factors for disease aggravation in patients with cancer and COVID-19 (Tian et al., 2020). This evidence concerns the gene IL6 and COVID-19.